407
Views
7
CrossRef citations to date
0
Altmetric
Theme: Epilepsy - Editorial

Antiepileptic drugs and suicide risk: could stopping medications pose a greater hazard?

&
Pages 1775-1776 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

Marco Mula has received travel grants or consultancy fees from various pharmaceutical companies including Novartis, Pfizer, UCB Pharma, Eisai, Janssen-Cilag and Sanofi-Aventis. Josemir W Sander has received travel grants or consultancy fees from various pharmaceutical companies including UCB Pharma, Eisai, Janssen-Cilag,and GSK – involved in the manufacture of antiepileptic drugs. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.